AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CHRYSALIS INVESTMENTS LIMITED

Director's Dealing May 30, 2022

5136_dirs_2022-05-30_4f833232-0a3e-48c6-a23e-317c910c521e.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1385N

Chrysalis Investments Limited

30 May 2022

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in Belgium, Denmark, the Republic of Ireland, Luxembourg, the Netherlands, Norway and Sweden), Canada, Australia, Japan or the Republic of South Africa.

30 May 2022

Chrysalis Investments Limited (the "Company")

Director/PDMR shareholding

The Company wishes to announce in accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation the following dealing in the Company's ordinary shares of no-par value by persons discharging managerial responsibility.

Details of the person discharging managerial responsibilities/person closely associated

Name

Anne Ewing

Reason for the notification

Position/status

Independent Director of the Board

Initial Notification / Amendment

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Chrysalis Investments Limited

LEI

213800F9SQ753JQHSW24

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial  instrument,

type  of

instrument

Identification code

Ordinary shares of no par value

ISIN: GG00BGJYPP46

Nature of the transaction  

Purchase

Price(s) and volume(s)

Price(s) Volume(s)
129.40p 15,000

Aggregated information

- Aggregated volume

- Price

N/A (Single Transaction)

Date of the transaction

27 May 2022

Place of the transaction

LONDON STOCK EXCHANGE, (XLON)

Additional Information

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation ("MAR") and the Company confirms that the PDMR's notification obligations under MAR have also been satisfied.

-ENDS-

For further information, please contact:

Jupiter Asset Management:

James Simpson
+44 (0) 20 3817 1325
Liberum Capital Limited:

Chris Clarke / Darren Vickers / Owen Matthews
+44 (0) 20 3100 2000
Numis Securities Limited:

Nathan Brown / Matt Goss
+44 (0) 20 7260 1000
Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier
+44 (0) 1481 749364
Media Enquiries:

Montfort Communications

Charlotte McMullen
+44 (0) 20 3514 0897

[email protected]

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at http://chrysalisinvestments.co.uk. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFIEEVIDFIF

Talk to a Data Expert

Have a question? We'll get back to you promptly.